Nelson PT - Search Results

1

Correction: Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer's disease.

Ray B, Maloney B, Sambamurti K, Karnati HK, Nelson PT, Greig NH, Lahiri DK. Ray B, et al. Among authors: nelson pt. Transl Psychiatry. 2020 Mar 2;10(1):81. doi: 10.1038/s41398-020-0757-2. Transl Psychiatry. 2020. PMID: 32123156 Free PMC article.

2

Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer's disease.

Ray B, Maloney B, Sambamurti K, Karnati HK, Nelson PT, Greig NH, Lahiri DK. Ray B, et al. Among authors: nelson pt. Transl Psychiatry. 2020 Feb 3;10(1):47. doi: 10.1038/s41398-020-0709-x. Transl Psychiatry. 2020. PMID: 32066688 Free PMC article.

3

Human microRNA (miR-20b-5p) modulates Alzheimer's disease pathways and neuronal function, and a specific polymorphism close to the MIR20B gene influences Alzheimer's biomarkers.

Wang R, Chopra N, Nho K, Maloney B, Obukhov AG, Nelson PT, Counts SE, Lahiri DK. Wang R, et al. Among authors: nelson pt. Mol Psychiatry. 2022 Feb;27(2):1256-1273. doi: 10.1038/s41380-021-01351-3. Epub 2022 Jan 27. Mol Psychiatry. 2022. PMID: 35087196 Free PMC article.

4

Neuroinflammatory phenotype in early Alzheimer's disease.

Sudduth TL, Schmitt FA, Nelson PT, Wilcock DM. Sudduth TL, et al. Among authors: nelson pt. Neurobiol Aging. 2013 Apr;34(4):1051-9. doi: 10.1016/j.neurobiolaging.2012.09.012. Epub 2012 Oct 9. Neurobiol Aging. 2013. PMID: 23062700 Free PMC article.

5

Is synaptic loss a unique hallmark of Alzheimer's disease?

Scheff SW, Neltner JH, Nelson PT. Scheff SW, et al. Among authors: nelson pt. Biochem Pharmacol. 2014 Apr 15;88(4):517-28. doi: 10.1016/j.bcp.2013.12.028. Epub 2014 Jan 9. Biochem Pharmacol. 2014. PMID: 24412275 Free PMC article. Review.

6

Reply: Selected cryptic exons accumulate in hippocampal cell nuclei in Alzheimer's disease with and without associated TDP-43 proteinopathy.

Nelson PT. Nelson PT. Brain. 2020 Mar 1;143(3):e21. doi: 10.1093/brain/awaa014. Brain. 2020. PMID: 32016396 Free PMC article. No abstract available.

7

LATE Neuropathologic Changes with Little or No Alzheimer Disease is Common and is Associated with Cognitive Impairment but Not Frontotemporal Dementia.

Nelson PT. Nelson PT. J Neuropathol Exp Neurol. 2021 Aug 11;80(7):649-651. doi: 10.1093/jnen/nlab050. J Neuropathol Exp Neurol. 2021. PMID: 34270750 Free PMC article.

8

Inflammatory Pathways Are Impaired in Alzheimer Disease and Differentially Associated With Apolipoprotein E Status.

Kloske CM, Dugan AJ, Weekman EM, Winder Z, Patel E, Nelson PT, Fardo DW, Wilcock DM. Kloske CM, et al. Among authors: nelson pt. J Neuropathol Exp Neurol. 2021 Oct 26;80(10):922-932. doi: 10.1093/jnen/nlab085. J Neuropathol Exp Neurol. 2021. PMID: 34486652 Free PMC article.

9

Human Gray and White Matter Metabolomics to Differentiate APOE and Stage Dependent Changes in Alzheimer's Disease.

Hammond TC, Xing X, Yanckello LM, Stromberg A, Chang YH, Nelson PT, Lin AL. Hammond TC, et al. Among authors: nelson pt. J Cell Immunol. 2021;3(6):397-412. doi: 10.33696/immunology.3.123. J Cell Immunol. 2021. PMID: 35265943 Free PMC article.

10

When Alzheimer's is LATE: Why Does it Matter?

Nelson PT, Schneider JA, Jicha GA, Duong MT, Wolk DA. Nelson PT, et al. Ann Neurol. 2023 Aug;94(2):211-222. doi: 10.1002/ana.26711. Epub 2023 Jun 12. Ann Neurol. 2023. PMID: 37245084 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

274 results

Search Page